Title: A European multicentre PET study of fibrillar amyloid in Alzheimer's disease
Authors: Nordberg, Agneta ×
Carter, Stephen F
Rinne, Juha
Drzezga, Alexander
Brooks, David J
Vandenberghe, Rik
Perani, Daniela
Forsberg, Anton
Långström, Bengt
Scheinin, Noora
Karrasch, Mira
Någren, Kjell
Grimmer, Timo
Miederer, Isabelle
Edison, Paul
Okello, Aren
Van Laere, Koen
Nelissen, Natalie
Vandenbulcke, Mathieu
Garibotto, Valentina
Almkvist, Ove
Kalbe, Elke
Hinz, Rainer
Herholz, Karl #
Issue Date: Jan-2013
Series Title: European journal of nuclear medicine and molecular imaging vol:40 issue:1 pages:104-114
Abstract: PURPOSE: Amyloid PET tracers have been developed for in vivo detection of brain fibrillar amyloid deposition in Alzheimer's disease (AD). To serve as an early biomarker in AD the amyloid PET tracers need to be analysed in multicentre clinical studies. METHODS: In this study 238 [(11)C]Pittsburgh compound-B (PIB) datasets from five different European centres were pooled. Of these 238 datasets, 18 were excluded, leaving [(11)C]PIB datasets from 97 patients with clinically diagnosed AD (mean age 69 ± 8 years), 72 patients with mild cognitive impairment (MCI; mean age 67.5 ± 8 years) and 51 healthy controls (mean age 67.4 ± 6 years) available for analysis. Of the MCI patients, 64 were longitudinally followed for 28 ± 15 months. Most participants (175 out of 220) were also tested for apolipoprotein E (ApoE) genotype. RESULTS: [(11)C]PIB retention in the neocortical and subcortical brain regions was significantly higher in AD patients than in age-matched controls. Intermediate [(11)C]PIB retention was observed in MCI patients, with a bimodal distribution (64 % MCI PIB-positive and 36 % MCI PIB-negative), which was significantly different the pattern in both the AD patients and controls. Higher [(11)C]PIB retention was observed in MCI ApoE ε4 carriers compared to non-ApoE ε4 carriers (p < 0.005). Of the MCI PIB-positive patients, 67 % had converted to AD at follow-up while none of the MCI PIB-negative patients converted. CONCLUSION: This study demonstrated the robustness of [(11)C]PIB PET as a marker of neocortical fibrillar amyloid deposition in brain when assessed in a multicentre setting. MCI PIB-positive patients showed more severe memory impairment than MCI PIB-negative patients and progressed to AD at an estimated rate of 25 % per year. None of the MCI PIB-negative patients converted to AD, and thus PIB negativity had a 100 % negative predictive value for progression to AD. This supports the notion that PIB-positive scans in MCI patients are an indicator of prodromal AD.
ISSN: 1619-7070
Publication status: published
KU Leuven publication type: IT
Appears in Collections:Non-KU Leuven Association publications
× corresponding author
# (joint) last author

Files in This Item:
File Description Status SizeFormat
2013 - A European multicentre PET study of fibrillar amyloid in Alzheimer's disease.pdfA European multicentre PET study of fibrillar amyloid in Alzheimer's disease Published 537KbAdobe PDFView/Open Request a copy

These files are only available to some KU Leuven Association staff members


All items in Lirias are protected by copyright, with all rights reserved.

© Web of science